-
February 24, 2026-Elite Treats, LLC. of Boca Raton, FL, is recalling a single lot of “Elite Treats Chicken Chips for Dogs” 6-ounce bags because it may be contaminated with Salmonella. The product is packaged in a 6-ounce black and gold bag marked on the back side with lot number 24045 and an expirat
-
FDA approves drug for adult and pediatric patients aged 6 and older with allergic fungal rhinosinusitis
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) with a history of sino-nasal surgery or for whom surgery is not advisable. This is the first approval for -
Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances.
-
MHRA approves imlunestrant tosylate (Inluryo) – a new treatment for breast cancer
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
-
A. Nelson & Co. Ltd. – 720283 – 02/12/2026
CGMP/Finished Pharmaceuticals/Adulterated -
AQ USA Inc., d.b.a Ross Healthcare Inc. – 719517 – 02/12/2026
CGMP/Finished Pharmaceuticals/Adulterated -
MedisourceRx – 717970 – 12/12/2025
Compounding Pharmacy/Adulterated Drug Products -
Class 4 Medicines Defect Notification: Rayner Pharmaceuticals Limited, Dropodex 0.1% w/v Eye Drops, solution, EL(26)A/10
Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information.
-
Falsified Mounjaro KwikPen 15mg pre-filled pens
A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only.
-
Regulation as an Enabler of Innovation: A Regional Perspective
By Richard Stubbs
-
Field Safety Notices: 16-20 February 2026
List of Field Safety Notices: 16-20 February 2026
-
Guidance Documents for Rare Disease Drug Development
Guidance Documents for Rare Disease Drug Development
